WIN site inhibitor 1;WDR5-IN-4;WDR5IN4,WDR-5-IN-4,WDR5 IN 4;Benzamide, N-[(3,4-dichlorophenyl)methyl]-3-[(2,3-dihydro-2-imino-3-methyl-1H-imidazol-1-yl)methyl]-5-(6-fluoro-2-methyl-3-pyridinyl)-
Anticancer agent; inhibits WDR5 by displacing it from chromatin, leading to downregulation of associated gene expression, translational suppression, and nucleolar stress.